Devilee P - Search Results

1

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.

Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Mai PL, Greene MH, Piedmonte M, Rubinstein WS; HEBON; Hogervorst FB, Rookus MA, Collée JM, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer HE, Van Roozendaal CE, Caldes T, Perez-Segura P, Jakubowska A, Lubinski J, Huzarski T, Blecharz P, Nevanlinna H, Aittomäki K, Lazaro C, Blanco I, Barkardottir RB, Montagna M, D'Andrea E; kConFab; Devilee P, Olopade OI, Neuhausen SL, Peissel B, Bonanni B, Peterlongo P, Singer CF, Rennert G, Lejbkowicz F, Andrulis IL, Glendon G, Ozcelik H; Ontario Cancer Genetics Network; Toland AE, Caligo MA; SWE-BRCA; Beattie MS, Chan S; UKFOCR; Domchek SM, Nathanson KL, Rebbeck TR, Phelan C, Narod S, John EM, Hopper JL, Buys SS, Daly MB, Southey MC, Terry MB, Tung N, Hansen TV, Osorio A, Benitez J, Durán M, Weitzel JN, Garber J, Hamann U; EMBRACE; Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Eeles R, Izatt L, Paterson J, Brewer C, Hodgson S, Morrison PJ, Porteous M, Walker L, Rogers MT, Side LE, Godwin AK, Schmutzler RK, Wappenschmidt B, Laitman Y,… See abstract for full author list ➔ Im KM, et al. Among authors: devilee p. Hum Genet. 2011 Nov;130(5):685-99. doi: 10.1007/s00439-011-1003-z. Epub 2011 May 20. Hum Genet. 2011. PMID: 21597964 Free PMC article.

2

Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.

Narod S, Ford D, Devilee P, Barkardottir RB, Eyfjord J, Lenoir G, Serova O, Easton D, Goldgar D. Narod S, et al. Among authors: devilee p. Am J Hum Genet. 1995 Oct;57(4):957-8. Am J Hum Genet. 1995. PMID: 7573057 Free PMC article. No abstract available.

3

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BA, Weber BL, Garber JE, Birch JM, et al. Narod SA, et al. Among authors: devilee p. Am J Hum Genet. 1995 Jan;56(1):254-64. Am J Hum Genet. 1995. PMID: 7825586 Free PMC article.

4

Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds.

Devilee P, Cornelis RS, Bootsma A, Bardoel A, van Vliet M, van Leeuwen I, Cleton FJ, de Klein A, Lindhout D, Vasen HF, et al. Devilee P, et al. Am J Hum Genet. 1993 Apr;52(4):730-5. Am J Hum Genet. 1993. PMID: 8096358 Free PMC article.

5

[Periodical screening of families with a hereditary predisposition for breast carcinoma].

Vasen HF, Devilee P. Vasen HF, et al. Among authors: devilee p. Ned Tijdschr Geneeskd. 1993 Nov 13;137(46):2350-4. Ned Tijdschr Geneeskd. 1993. PMID: 8264817 Dutch. No abstract available.

6

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.

Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA. Phelan CM, et al. Among authors: devilee p. Nat Genet. 1996 Mar;12(3):309-11. doi: 10.1038/ng0396-309. Nat Genet. 1996. PMID: 8589723

7

First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).

Oosterwijk JC, Jansen JC, van Schothorst EM, Oosterhof AW, Devilee P, Bakker E, Zoeteweij MW, van der Mey AG. Oosterwijk JC, et al. Among authors: devilee p. J Med Genet. 1996 May;33(5):379-83. doi: 10.1136/jmg.33.5.379. J Med Genet. 1996. PMID: 8733047 Free PMC article.

8

The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.

Peelen T, Cornelis RS, van Vliet M, Petrij-Bosch A, Cleton-Jansen AM, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, Devilee P. Peelen T, et al. Among authors: devilee p. Eur J Hum Genet. 1996;4(4):225-30. doi: 10.1159/000472203. Eur J Hum Genet. 1996. PMID: 8875189

9

Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes.

van Schothorst EM, Jansen JC, Bardoel AF, van der Mey AG, James MJ, Sobol H, Weissenbach J, van Ommen GJ, Cornelisse CJ, Devilee P. van Schothorst EM, et al. Among authors: devilee p. Eur J Hum Genet. 1996;4(5):267-73. doi: 10.1159/000472213. Eur J Hum Genet. 1996. PMID: 8946172

10

Three germline mutations in the TP53 gene.

Cornelis RS, van Vliet M, van de Vijver MJ, Vasen HF, Voute PA, Top B, Khan PM, Devilee P, Cornelisse CJ. Cornelis RS, et al. Among authors: devilee p. Hum Mutat. 1997;9(2):157-63. doi: 10.1002/(SICI)1098-1004(1997)9:2<157::AID-HUMU8>3.0.CO;2-6. Hum Mutat. 1997. PMID: 9067756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page